Alfonso Quintás-Cardama
Chief Tech/Sci/R&D Officer at FOGHORN THERAPEUTICS INC.
Net worth: - $ as of 2024-03-30
Alfonso Quintás-Cardama active positions
| Companies | Position | Start | End |
|---|---|---|---|
| FOGHORN THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2023-09-10 | - |
Career history of Alfonso Quintás-Cardama
Former positions of Alfonso Quintás-Cardama
| Companies | Position | Start | End |
|---|---|---|---|
The University of Texas M.D. Anderson Cancer Center
 The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Corporate Officer/Principal | 2008-12-31 | 2013-12-31 |
| GSK PLC | Corporate Officer/Principal | - | - |
| TCR2 THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2016-12-31 | - |
Training of Alfonso Quintás-Cardama
| University of Santiago de Compostela | Doctorate Degree |
Statistics
International
| United States | 4 |
| United Kingdom | 2 |
| Spain | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| GSK PLC | Health Technology |
| FOGHORN THERAPEUTICS INC. | Health Technology |
| Private companies | 2 |
|---|---|
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Consumer Services |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA. | Health Technology |